Pazopanib: an orally administered multi-targeted tyrosine kinase Inhibitor for locally advanced or metastatic renal cell carcinoma
Department of Urology, Tepecik Teaching and Research Hospital, Yenisehir, Izmir, Turkey
Dec
2011 (Vol.
18, Issue
6, Pages(
5991 - 5997)
PMID: 22166325